Basel, Switzerland

Adrian Schaeublin

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 12.2

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: The Innovative Mind of Adrian Schaeublin

Introduction

Adrian Schaeublin, a prominent inventor based in Basel, Switzerland, has made significant contributions to the field of biochemistry through his innovative research and patented inventions. With a total of five patents to his name, Schaeublin has played an essential role in advancing scientific knowledge and technology.

Latest Patents

Among his latest innovations, Schaeublin has developed peptide macrocycles aimed at addressing various biochemical challenges. His present invention encompasses compounds of formula (I), which are designed to enhance the efficacy and scope of peptide applications. Furthermore, he has contributed to the field by creating thiophosphoramidites, which relate to a compound of formula (II) or (IIb). The specifications define various components such as X, Y, R, and Nu, with significant potential in the manufacture of oligonucleotides.

Career Highlights

Adrian Schaeublin has built a robust career within major pharmaceutical companies, including Hoffmann-La Roche Inc. and Roche Innovation Center Copenhagen A/S. His work in these institutions has allowed him to focus on translating scientific discoveries into practical applications, making a meaningful impact on healthcare and research.

Collaborations

Throughout his career, Schaeublin has collaborated with esteemed colleagues, including Konrad H. Bleicher and Bernhard Fasching. These partnerships have fostered an environment of shared knowledge and innovation, further enhancing the scope of their collective work in the scientific community.

Conclusion

Adrian Schaeublin's inventive spirit and unrelenting pursuit of innovation have established him as a noteworthy figure in the biotechnology sector. With five patents under his belt and a commitment to collaborative research, Schaeublin continues to pave the way for future advancements in the field. His contributions not only enrich scientific understanding but also hold promise for the development of novel therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…